financetom
Business
financetom
/
Business
/
Team Q2 revenue rises 8.5% to $248 mln
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Team Q2 revenue rises 8.5% to $248 mln
Aug 12, 2025 1:35 PM

Overview

* Team Q2 revenue rises 8.5% yr/yr to $248 mln, driven by Inspection and Heat Treating segment

* Adjusted EBITDA grows 12.4% to $24.5 mln, despite net loss of $4.3 mln

* Company highlights progress in transformation initiatives and cost optimization

Outlook

* Company expects at least 15% year-over-year growth in Adjusted EBITDA

* Team anticipates second half top-line growth across both segments

* Company foresees improved Adjusted EBITDA levels in second half of 2025

* Team expects continued improvement in Canadian and international operations

Result Drivers

* IHT SEGMENT GROWTH - Revenue from Inspection and Heat Treating segment rose 15.2%, driven by increased U.S. and Canada activity

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 $248.03

Revenue mln

Q2 $179.94

Operatin mln

g

Expenses

Q2 $12.10

Operatin mln

g Income

Q2 -$3.28

Pretax mln

Profit

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CRA International Insider Sold Shares Worth $1,166,265, According to a Recent SEC Filing
CRA International Insider Sold Shares Worth $1,166,265, According to a Recent SEC Filing
Mar 20, 2026
04:15 AM EDT, 03/20/2026 (MT Newswires) -- Paul A Maleh, Director, President and Chief Executive Officer, on March 17, 2026, sold 7,500 shares in CRA International ( CRAI ) for $1,166,265. Following the Form 4 filing with the SEC, Maleh has control over a total of 115,113 common shares of the company, with 115,113 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1053706/000137916026000013/xslF345X05/form4-03192026_090322.xml...
BRIEF-German Cartel Office Gives Preliminary Approval To Adobe's Planned Acquisition Of Semrush Holdings
BRIEF-German Cartel Office Gives Preliminary Approval To Adobe's Planned Acquisition Of Semrush Holdings
Mar 20, 2026
March 20 (Reuters) - Adobe Inc ( ADBE ): * GERMAN CARTEL OFFICE: GIVES PRELIMINARY APPROVAL TO ADOBE'S PLANNED ACQUISITION OF SEMRUSH HOLDINGS Source text: Further company coverage: ...
Stoke Therapeutics Insider Sold Shares Worth $285,901, According to a Recent SEC Filing
Stoke Therapeutics Insider Sold Shares Worth $285,901, According to a Recent SEC Filing
Mar 20, 2026
04:15 AM EDT, 03/20/2026 (MT Newswires) -- Jonathan Allan, General Counsel and Corporate Secretary, on March 17, 2026, sold 8,895 shares in Stoke Therapeutics ( STOK ) for $285,901. Following the Form 4 filing with the SEC, Allan has control over a total of 28,836 common shares of the company, with 28,836 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/xslF345X05/form4-03192026_090304.xml ...
Market Chatter: Eli Lilly Alzheimer's Drug to be Reconsidered by UK Health Regulator
Market Chatter: Eli Lilly Alzheimer's Drug to be Reconsidered by UK Health Regulator
Mar 20, 2026
04:13 AM EDT, 03/20/2026 (MT Newswires) -- Eli Lilly's ( LLY ) Alzheimer's drug will be reassessed by the National Institute for Health and Care Excellence after a successful appeal against a prior decision blocking its use in the state-run National Health Service, Bloomberg reported Friday. The regulator will review earlier guidance that found the benefits of donanemab, marketed as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved